Efficacy and Toxicological Studies of Cremophor EL Free Alternative Paclitaxel Formulation

Publisher： Bentham Science Publishers

E-ISSN： 2212-3911|6|5|329-338

ISSN： 1574-8863

Source： Current Drug Safety, Vol.6, Iss.5, 2011-11, pp. : 329-338

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-Cancer, Pharmacokinetic and Biodistribution Studies of Cremophor EL Free Alternative Paclitaxel Formulation

By  

Current Drug Safety, Vol. 9, Iss. 2, 2014-07 ,pp. : 145-155

Bentham Science Publishers

Access to resources Recommend Favorite

Nanoparticle albumin-bound paclitaxel: a novel Cremphor-EL®®-free formulation of paclitaxel

By Stinchcombe Thomas E  

Nanomedicine, Vol. 2, Iss. 4, 2007-08 ,pp. : 415-423

Future Medicine

Access to resources Recommend Favorite

Preliminary in vivo studies of a new lecithin-based formulation of paclitaxel

By Sznitowska Malgorzata   Bodnar Malgorzata   Petrusewicz Jacek   Janik Helena   Dabrowska Ewa Anna  

Journal of Microencapsulation, Vol. 26, Iss. 7, 2009-11 ,pp. : 588-592

Informa Healthcare

Access to resources Recommend Favorite

Taxol ® -induced phosphatidylserine exposure and microvesicle formation in red blood cells is mediated by its vehicle Cremophor ® EL

By Vader Pieter   Fens Marcel HAM   Sachini Nikoleta   van Oirschot Brigitte A   Andringa Grietje   Egberts Antoine CG   Gaillard Carlo AJM   Rasmussen Jan T   van Wijk Richard   van Solinge Wouter W   Schiffelers Raymond M  

Nanomedicine, Vol. 8, Iss. 7, 2013-07 ,pp. : 1127-1135

Future Medicine

Access to resources Recommend Favorite

Clinical Studies on the Efficacy and Safety of Padma 28, a Complex Herbal Formulation from Tibetan Medicine: An Overview

By  

Forschende Komplementärmedizin / Research in Complementary Medicine, Vol. 20, Iss. 2, 2013-06 ,pp. : 25-30

Karger

Access to resources Recommend Favorite